Recently, a research team led by Prof. WANG Hongzhi from the Hefei Institutes of Physical Science, Chinese Academy of Sciences, has developed a programmable plasmonic ring biosensor, MetaRing, capable ...

After Reevaluating its Near-term Capital Needs Given the Recent Changes in its Projected 2026 Revenue and Mayo Collaboration, the Company Determined that a $15 Million Offering is Not Required to ...

Shares of biosensor company Profusa declined after it announced an equity offering. The stock opened at $2.76 Friday, remained below Thursday's close of $3.02 throughout the day, with a sharp decline ...

Profusa (Nasdaq:PFSA) and Mayo Clinic today announced a know-how agreement related to oxygen monitoring technologies. Berkeley, California-based Profusa develops a next-generation platform aiming to ...

Study conducted at US sites evaluates LumeeTM in peripheral artery disease (PAD) patients BERKELEY, Calif, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), ...

(RTTNews) - Profusa, Inc. (PFSA) has taken a significant step toward commercializing its biosensor technology with the launch of its Lumee tissue-oxygen healthcare and research offerings, a move that ...

Profusa, Inc. (NASDAQ: PFSA) stock rallied on Friday as the company is launching its Healthcare Research version of the Lumee tissue oxygen monitoring system. The stock is trading with a massive ...

Dr. Theodosios Bisdas is a renowned vascular surgeon and Head of Clinic of Vascular Surgery at the Athens Medical Center BERKELEY, Calif, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or ...

A portable biosensor developed at La Trobe University may allow rapid, on-site detection of toxic "forever chemicals" in water, removing the need for samples to be sent to specialist laboratories. The ...

New note provides greater repayment flexibility and less dilution with elimination of mandatory amortization payments, increased conversion floor price to $0.35, and expanded mandatory ELOC payments ...